Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 110

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Anticancer activity of limonene: A systematic review of target signaling pathways

Araújo‐Filho, Heitor Gomes de, dos Santos, Jucilene F., Carvalho, Mikaella T. B., Picot, Laurent, Fruitier‐Arnaudin, Ingrid, Groult, Hugo, Quintans‐Júnior, Lucindo J., Quintans, Jullyana S.S.·2021·Phytotherapy Research

Abstract

Limonene (LIM) is a monoterpene, which is abundant in essential oils of Citrus fruits peels (Rutaceae). More recently, LIM, as a potential natural anticancer compound, has attracted major attention and exerted a chemopreventive activity, stimulating the detoxification of carcinogenic compounds and limiting tumor growth and angiogenesis in various cancer models. Twenty‐six (26) articles were selected based on previously established criteria. Anticancer activity of LIM was related to the inhibition of tumor initiation, growth, and angiogenesis and the induction of cancer cells apoptosis. LIM was able to increase Bax expression, release cytochrome c, and activate the caspase pathway. In addition, LIM increased the expression of p53 and decreased the activity of Ras/Raf/MEK/ERK and PI3K/Akt pathways. LIM also decreased the expression of VEGF and increased the activities of the Man‐6‐P / IGF2R and TGF‐βIIR receptors. These results highlight LIM as an abundant natural molecule with low toxicity and pleiotropic pharmacological activity in cancer cells, targeting various cell‐signaling pathways critically involved in the initiation, growth, and chemoresistance of cancer cells.

Overview

Integrity signals

Registry

Crossref · 10.1002/ptr.7125

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 5 references

Research works printed but not linked: 108

  1. 10.1016/j.colsurfb.2018.03.051 · DOI
  2. 10.1016/j.ijpharm.2018.12.042 · DOI
  3. 10.3390/ma13092073 · DOI
  4. 10.1016/j.lwt.2019.02.071 · DOI
  5. 10.1074/jbc.271.46.29286 · DOI
  6. 10.1007/s00520-014-2474-y · DOI
  7. 10.1016/j.ijbiomac.2020.04.044 · DOI
  8. 10.1016/j.ijpharm.2015.09.054 · DOI
  9. 10.3892/ijmm.2017.2903 · DOI
  10. 10.1517/14728222.2011.644788 · DOI
  11. 10.1016/j.phymed.2018.01.005 · DOI
  12. 10.1007/978-981-15-0202-6_19 · DOI
  13. 10.1007/s10787-017-0374-8 · DOI
  14. 10.1016/0959-8049(95)00168-I · DOI
  15. 10.1074/jbc.274.34.24408 · DOI
  16. 10.1159/000088478 · DOI
  17. 10.1038/onc.2008.247 · DOI
  18. 10.1177/0960327111434948 · DOI
  19. 10.1016/j.bmc.2006.06.013 · DOI
  20. Chen X., 1999, Inhibition of farnesyl protein transferase and P21ras memebrane association by d‐limonene in human pancreas tumor cells in vitro, Chinese Medical Sciences Journal, 14, 138
  21. 10.1186/1477-7819-11-118 · DOI
  22. 10.1007/s11101-009-9123-y · DOI
  23. 10.1159/000443404 · DOI
  24. 10.1093/jn/129.3.775S · DOI
  25. 10.2147/NSA.S156115 · DOI
  26. 10.3390/biom9040138 · DOI
  27. 10.1016/j.fitote.2018.02.025 · DOI
  28. 10.1016/j.intimp.2004.12.012 · DOI
  29. 10.1016/j.jbiotec.2011.07.001 · DOI
  30. 10.1021/acssuschemeng.5b00446 · DOI
  31. 10.1093/carcin/14.6.1221 · DOI
  32. 10.1038/nrc2403 · DOI · Paper page
  33. 10.1016/j.foodchem.2016.12.030 · DOI
  34. 10.1016/0092-8674(92)90123-t · DOI
  35. 10.1002/ijc.29210 · DOI · Paper page
  36. 10.3892/or.6.5.1123 · DOI
  37. 10.1038/nrc3627 · DOI
  38. 10.1016/j.cell.2013.11.019 · DOI
  39. 10.2174/1568009617666171114144236 · DOI
  40. 10.4103/1735-5362.268206 · DOI
  41. 10.1016/j.cell.2011.02.013 · DOI · Paper page
  42. 10.1038/35037710 · DOI · Paper page
  43. 10.1159/000068621 · DOI
  44. 10.3390/molecules25112598 · DOI
  45. 10.1016/j.ijbiomac.2013.06.028 · DOI
  46. 10.5483/bmbrep.2008.41.1.011 · DOI
  47. 10.1136/bmjopen-2018-023625 · DOI
  48. 10.3892/or.2012.2093 · DOI · Paper page
  49. Jirtle R. L., 1993, Increased mannose 6‐phosphate/insulin‐like growth factor II receptor and transforming growth factor beta 1 levels during monoterpene‐induced regression of mammary tumors, Cancer Research, 53, 3849
  50. 10.1002/ijc.1353 · DOI
  51. 10.1038/nrd2155 · DOI
  52. 10.1016/j.lwt.2006.10.008 · DOI
  53. 10.1038/bjc.1994.199 · DOI
  54. 10.1101/gad.17558811 · DOI
  55. 10.4161/auto.2.2.2457 · DOI
  56. Lu X., 2003, D‐limonene induces apoptosis of gastric cancer cells, Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology], 25, 325
  57. 10.3748/wjg.v10.i14.2140 · DOI
  58. 10.1093/carcin/12.11.2081 · DOI
  59. 10.1002/ptr.2743 · DOI
  60. 10.3109/07357900903179583 · DOI
  61. 10.1038/onc.2011.160 · DOI
  62. 10.1158/1940-6207.CAPR-12-0452 · DOI
  63. 10.1007/s12156-010-0066-8 · DOI
  64. 10.3322/caac.21565 · DOI
  65. 10.1038/s41598-019-48180-7 · DOI
  66. 10.1371/journal.pmed.1000097 · DOI · Paper page
  67. 10.1042/BSR20181253 · DOI
  68. 10.3390/pharmaceutics3040793 · DOI
  69. 10.1016/j.bcp.2010.07.021 · DOI
  70. 10.1021/jm0704090 · DOI
  71. 10.1007/978-1-4684-5442-0_17 · DOI
  72. 10.1021/jf0507893 · DOI
  73. 10.1016/j.powtec.2013.11.005 · DOI
  74. 10.1023/a:1022207630482 · DOI
  75. 10.1016/s0006-2952(03)00504-5 · DOI
  76. 10.14382/epitoanyag-jsbcm.2019.14 · DOI
  77. 10.1016/j.reactfunctpolym.2020.104571 · DOI
  78. 10.1093/carcin/15.4.787 · DOI
  79. 10.1371/journal.pone.0113682 · DOI
  80. Saffari M., 2016, Terpene‐loaded liposomes and isopropyl Myristate as chemical permeation enhancers toward liposomal gene delivery in lung cancer cells; A comparative study, Iranian Journal of Pharmaceutical Research, 15, 261
  81. Sakamuro D., 1995, C‐Myc induces apoptosis in epithelial cells by both p53‐dependent and p53‐independent mechanisms, Oncogene, 11, 2411
  82. 10.1007/s11947-017-1897-0 · DOI
  83. 10.1210/en.2002-220751 · DOI
  84. 10.1110/ps.04789804 · DOI
  85. 10.3322/caac.21590 · DOI · Paper page
  86. 10.1007/s13197-018-3198-7 · DOI
  87. 10.3390/ijms21041449 · DOI
  88. 10.1007/82_2017_4 · DOI
  89. 10.1155/2013/102735 · DOI
  90. Sun J., 2007, D‐limonene: Safety and clinical applications, Alternative Medicine Review: A Journal of Clinical Therapeutic, 12, 259
  91. 10.1016/j.biocel.2004.05.009 · DOI
  92. 10.1080/1040841X.2020.1782339 · DOI
  93. 10.1016/s0304-3835(98)00340-1 · DOI
  94. 10.1016/j.postharvbio.2017.02.007 · DOI
  95. 10.1021/acs.jafc.0c01184 · DOI
  96. 10.1007/s002800050793 · DOI · Paper page
  97. Visconti R., 2009, New insights on oxidative stress in cancer, Current Opinion in Drug Discovery & Development, 12, 240
  98. 10.1016/j.carbpol.2014.06.051 · DOI
  99. 10.1016/0163-7258(96)00065-4 · DOI
  100. 10.1016/j.lwt.2019.108947 · DOI
  101. 10.1021/acs.jafc.7b00147 · DOI
  102. 10.3781/j.issn.1000-7431.2008.11.007 · DOI
  103. 10.1002/(sici)1097-0215(19990827)82:5<665::aid-ijc8>3.0.co;2-e · DOI
  104. Ye Z., 2020, Limonene terpenoid obstructs human bladder cancer cell (T24 cell line) growth by inducing cellular apoptosis, caspase activation, G2/M phase cell cycle arrest and stops cancer metastasis, Journal of B.U.ON.: Official Journal of the Balkan Union of Oncology, 25, 280
  105. 10.1016/j.canlet.2007.07.020 · DOI
  106. 10.2147/OTT.S155716 · DOI
  107. 10.1615/critrevoncog.v16.i3-4.30 · DOI
  108. 10.1089/jmf.2013.2967 · DOI

Cited by

See all 110

Metadata

Authors
Araújo‐Filho, H. G. D., dos Santos, J. F., Carvalho, M. T. B., Picot, L., Fruitier‐Arnaudin, I., Groult, H., Quintans‐Júnior, L. J., & Quintans, J. S. S.
Affiliations
  • Laboratory of Neuroscience and Pharmacological Assays (LANEF), Department of Physiology Federal University of Sergipe São Cristóvão Brazil
  • Laboratory of Neuropharmacology and Integrative Physiology (LNFI), Department of Physiology Federal University of Alagoas Maceió Brazil
  • UMRi CNRS 7266 LIENSs University of La Rochelle La Rochelle France
Venue
Phytotherapy Research
Publisher
Wiley
Published
2021-04-17
Volume
35
Issue
9
Pages
4957-4970
ISSN
  • 0951-418X
  • 1099-1573
Cited by
110
References
5
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Anticancer activity of limonene: A systematic review of target signaling pathways. https://app.cochat.ai/papers/10.1002/ptr.7125
The paper
Araújo‐Filho, H. G. D., dos Santos, J. F., Carvalho, M. T. B., Picot, L., Fruitier‐Arnaudin, I., Groult, H., Quintans‐Júnior, L. J., & Quintans, J. S. S. (2021). Anticancer activity of limonene: A systematic review of target signaling pathways. Phytotherapy Research. https://doi.org/10.1002/ptr.7125

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.